85 related articles for article (PubMed ID: 1845128)
1. Clinical applications of recombinant macrophage-colony stimulating factor (rhM-CSF).
VandePol CJ; Garnick MB
Biotechnol Ther; 1991; 2(3-4):231-9. PubMed ID: 1845128
[TBL] [Abstract][Full Text] [Related]
2. Human recombinant macrophage colony stimulating factor activates murine Kupffer cells to a cytotoxic state.
Curley SA; Roh MS; Kleinerman E; Klostergaard J
Lymphokine Res; 1990; 9(3):355-63. PubMed ID: 2118971
[TBL] [Abstract][Full Text] [Related]
3. Alterations in phenotype and cell-surface antigen expression levels of human monocytes: differential response to in vivo administration of rhM-CSF or rhGM-CSF.
Schmid I; Baldwin GC; Jacobs EL; Isacescu V; Neagos N; Giorgi JV; Glaspy JA
Cytometry; 1995 Jun; 22(2):103-10. PubMed ID: 7587740
[TBL] [Abstract][Full Text] [Related]
4. Preclinical and clinical evaluation of recombinant human macrophage colony-stimulating factor (rhM-CSF).
Garnick MB; Stoudemire JB
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():356-71; discussion 371-3. PubMed ID: 2182744
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human macrophage-colony stimulating factor suppresses the mouse mixed lymphocyte reaction.
Sakurai T; Yamada M; Simamura S; Motoyoshi K
Cell Immunol; 1996 Jul; 171(1):87-94. PubMed ID: 8660842
[TBL] [Abstract][Full Text] [Related]
6. Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2.
Vallera DA; Taylor PA; Aukerman SL; Blazar BR
Cancer Res; 1993 Sep; 53(18):4273-80. PubMed ID: 8364923
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancer.
Saleh MN; Khazaeli MB; Wheeler RH; Bucy RP; Liu T; Everson MP; Munn DH; Schlom J; LoBuglio AF
Cancer Res; 1995 Oct; 55(19):4339-46. PubMed ID: 7671245
[TBL] [Abstract][Full Text] [Related]
8. The effect of cytokines on the ploidy of megakaryocytes.
Teramura M; Mizoguchi H
Int J Cell Cloning; 1990 Jul; 8(4):245-52. PubMed ID: 2205662
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human granulocyte-colony stimulating factor and recombinant human macrophage-colony stimulating factor synergize in vivo to enhance proliferation of granulocyte-macrophage, erythroid, and multipotential progenitor cells in mice.
Broxmeyer HE; Williams DE; Cooper S; Hangoc G; Ralph P
J Cell Biochem; 1988 Oct; 38(2):127-36. PubMed ID: 2464604
[TBL] [Abstract][Full Text] [Related]
10. Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro.
Jin-Xiang F; Xiaofeng S; Jun-Chuan Q; Yan G; Xue-Guang Z
Exp Hematol; 2004 Dec; 32(12):1204-11. PubMed ID: 15588945
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactive macrophage colony-stimulating factor is increased in atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits after recombinant human macrophage colony-stimulating factor therapy.
Donnelly LH; Bree MP; Hunter SE; Keith JC; Schaub RG
Mol Reprod Dev; 1997 Jan; 46(1):92-5. PubMed ID: 8981369
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
Hübel K; Dale DC; Liles WC
J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
[TBL] [Abstract][Full Text] [Related]
14. Macrophage colony-stimulating factor accelerates wound healing and upregulates TGF-beta1 mRNA levels through tissue macrophages.
Wu L; Yu YL; Galiano RD; Roth SI; Mustoe TA
J Surg Res; 1997 Oct; 72(2):162-9. PubMed ID: 9356238
[TBL] [Abstract][Full Text] [Related]
15. Modulation of human alveolar macrophage tumoricidal activity by recombinant macrophage colony-stimulating factor.
Thomassen MJ; Barna BP; Wiedemann HP; Ahmad M
J Biol Response Mod; 1990 Feb; 9(1):87-91. PubMed ID: 2156955
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic effects of cytokines: clinical and preclinical studies.
Bukowski RM; Olencki T; McLain D; Finke JH
Stem Cells; 1994; 12 Suppl 1():129-40; discussion 140-1. PubMed ID: 7696957
[TBL] [Abstract][Full Text] [Related]
17. Macrophage colony-stimulating factor enhancement of antibody-dependent cellular cytotoxicity against human colon carcinoma cells.
Qi CF; Nieroda C; De Filippi R; Greiner JW; Correale P; Schlom J; Tsang KY
Immunol Lett; 1995; 47(1-2):15-24. PubMed ID: 8537095
[TBL] [Abstract][Full Text] [Related]
18. Effects of macrophage colony-stimulating factor on the proliferation and the function of Kupffer cells.
Urano F; Imoto M; Fukuda Y; Koyama K; Nakano I
Arzneimittelforschung; 1993 Jul; 43(7):804-7. PubMed ID: 8369016
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of differential effects of cytokines on mast cells derived from murine bone marrow and peripheral blood mononuclear cells.
Rottem M; Hull G; Metcalfe DD
Exp Hematol; 1994 Nov; 22(12):1147-55. PubMed ID: 7523167
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of recombinant granulocyte macrophage colony-stimulating factor on human monocytes and alveolar macrophages.
Thomassen MJ; Barna BP; Rankin D; Wiedemann HP; Ahmad M
Cancer Res; 1989 Aug; 49(15):4086-9. PubMed ID: 2545332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
